You have access
Liprin-α4 as a New Therapeutic Target for SCLC as an Upstream Mediator of HIF1α
HIDEYA ONISHI, AKIO YAMASAKI, KATSUYA NAKAMURA, SHU ICHIMIYA, KOSUKE YANAI, MASAYO UMEBAYASHI, SHUNTARO NAGAI and TAKASHI MORISAKI
Anticancer Research March 2019, 39 (3) 1179-1184; DOI: https://doi.org/10.21873/anticanres.13227